Manager Sales

JOHN F. DAHLER, CPA, CMA

**** ******* *****, *** *****, MI 48103 • 734-***-**** • *******@*****.*** SUMMARY OF QUALIFICATIONS

A senior finance executive with a diverse business background in biotechnology, manufacturing and service environments ranging in size from Fortune 500 to start-up entrepreneurial businesses. Broad operational and international management experience including acquisitions, integration and management team development.

• Start-up company business planning and process implementation

• Business sale and venture-backed capital raising

• Domestic and international mergers and acquisitions on both the buy and sell side

• International operations management

• Operational knowledge and management skills

• Strategic planning with executive management and board of directors WORK EXPERIENCE

Optofluidic Bioassay, LLC 2015- Present

Part-time Chief Executive Officer overseeing operational and financial aspects of this start-up company formed in 2015 reporting to the co-founders. Actively involved in fund raising, contract negotiations and establishing sound business practices to ensure the scalability of the company following launch of their unique, patent pending ELISA test systems. Independent Consultant, Ann Arbor, MI 2014-Present I work with several early-stage companies as in-resident Chief Financial Officer and operations role. I primarily assist these companies with developing strategic business plans, financial projections, business plans for potential investors, fund raising (from pre-seed to venture backed), establish financial reporting systems, and operational support (developing business processes, establishing and negotiating customer and supply contracts, establishment of industry specific quality systems ISO 9001, ISO 13485, CLIA, Gmp). I am currently working with several clients that range from applied materials, medical device and therapeutics.

University of Michigan, Ann Arbor, MI 2014-2016

MENTOR IN-RESIDENCE

Working with the Office of Technology Transfer at the University of Michigan, this position provides me the opportunity me to work with U of M technologies to help them work on a business plan to determine the best course of action (license or spin-out as a start-up). I am currently working with four companies at various stages. My focus is on medical device companies that currently includes a novel reagent platform, a new 96 well platform and an enabling technology for the enhanced functionality of prosthetic limbs.

WorkForce Software LLC, Livonia, MI 2013-2014

FULL TIME CONTRACTOR

Worked for the CFO from October 2013-February 2014 to assist in evaluating the department structure and provide day-to- day continuity in the finance department during an acquisition process by the company. Worked with the CFO to restructure the team, including hiring a controller and financial systems manager, had direct responsibility for integrating the acquisition of a foreign subsidiary, and helped identify an ERP system to meet this rapidly growing company’s needs. Delphinus Medical Technologies Inc., Plymouth, MI 2011-2013 CHIEF FINANCIAL OFFICER

First CFO for this venture backed start-up medical device company that was formed in 2010. I was responsible for all financial, HR and supply chain functions within the company and served on the executive committee that also includes the company’s CEO, COO and CTO. As this company was in the pre-revenue stage, my primary focus had been on fund raising and establishing business procedures to carry the company into its commercialization growth stage. During my period as CFO, the company completed its commercial prototype system (SoftVue) and filed its first 510(k). Key accomplishments achieved during my tenure include:

• Establish baseline financial system and processes to facilitate the company’s evolution from start-up to commercialization

• Establish key contracts with suppliers

• Led all financial aspects for the application and on-going financial reporting for two NIH grants totaling over $2M

• Led two venture backed fund raising efforts that totaled over $20M including $6M of venture debt without financial covenants

Accuri Cytometers Inc., Ann Arbor, MI 2009-2011

CHIEF FINANCIAL OFFICER

First CFO for this $20MM venture backed innovative flow cytometry company. I was responsible for the Finance, Accounting, IT, HR and Administration functions of the company. Played a key role in successfully selling the company to Becton Dickinson in March 2011 for a multiple in excess of 10X revenues and a 5.5x money-on-money return to the investors. Key accomplishments achieved during my two year tenure included:

• Established business processes required to move the company from a development stage to a fast-paced commercial growth company, including the integration of foreign operations.

• Oversaw the company-wide ERP implementation (MS Dynamics)

• Designed and implemented the company’s incentive compensation programs including a novel equity-based incentive plan for senior management

• Led the start-up and integration of the company’s U.K. subsidiary (consolidated financial reporting and planning, transfer price agreement, inter-company line of credit)

• Developed the IT strategy including the establishment of an IT department and business processes and controls

• Led two venture backed fund raisings of $4MM and $6MM, respectively

• Established a $2M working capital line of credit with limited debt covenants

• Oversaw the supply chain group during the period of manufacturing head replacement; set-up the supply chain business processes and objectives and staffed the planner/buyer and inventory manager positions.

• Key member of the ISO 13485 implementation team

Asuragen Inc., Austin, TX (A spin-off of Ambion, Inc.) 2006-2009 CHIEF FINANCIAL OFFICER and VICE PRESIDENT OF BUSINESS OPERATIONS Responsible for Finance, Accounting, IT, Customer Service, Supply Chain Management, Benefits Management, and Facilities Management. As a founding executive of the company, I played a central role in establishing the business operations during the start-up. Successfully closed two financing rounds and the spin-off of the company’s therapeutics assets into a separate company to enable financing for our early-stage miRNA therapeutics business.

• Took the lead role in all operational aspects of the start-up of the company, while also overseeing the close of the Ambion, Inc. sale. Responsibilities included establishing corporate records and processes, staffing of key functional management, new facility build-out and fund raising.

• Worked with outside counsel to prepare offering memorandum to raise $48 MM in a venture-backed Series-A Preferred Stock offering in 2006 and a venture-backed Series-B Preferred Stock offering for $19 MM in 2007.

• Work closely with business development and general counsel on the company’s licensing and grant funding initiatives.

• Worked with the President to negotiate and close multiple distributor agreement for the international distribution of the company’s diagnostic products.

• Established and manage the company’s stock incentive and investment policies and strategies Ambion, Inc., Austin, TX 2004-2006

CHIEF FINANCIAL OFFICER

First CFO of this $60 MM privately-held diversified biotechnology company. Responsible for Finance and Accounting, IT and Purchasing. Played a key role in successfully selling the Research Products division of the company to Applera/ABI in March 2006 for a multiple in excess of 5X revenues. Established financial systems and restructured the finance team which was critical to the successful sale of the company.

• Established foundational accounting systems, controls and staff to bring Ambion into a public-like company in terms of financial reporting.

• Key member of a small management team that prepared Ambion, Inc. for sale through a competitive bid process, including: selection of investment banker (JPMorgan), preparing offering memorandum, preparing and presenting company presentation to six potential buyers, preparing due diligence materials, negotiating with four potential investors, negotiating definitive agreement and final purchase with Applera/ABI.

• Played a key role in establishing a subsidiary in Japan resulting in higher and more profitable Pac Asia sales.

• Led a team to determine whether to build or buy a new pharmacogenomic services business. Prepared two purchase offers of smaller niche companies that were ultimately too costly. Developed build financial analysis and successfully obtained Board approval to start this new division.

• Re-negotiated bank line of credit from $2M to $12M to fund early stage discovery R&D in miRNA and expansion into the pharmacogenomic services business.

• Developed a new accounting and budgetary reporting structure which introduced department manager accountability. Developed a balanced scorecard and company metrics to measure and improve upon the performance of Ambion from the customer to internal processes.

• Designed and oversaw the development of a sales and financial data warehouse to improve sales and profit management efforts.

Promega Corporation, Madison, WI 2001-2004

DIRECTOR OF FINANCE AND ACCOUNTING

Responsible for global finance, accounting and tax related matters for a $150 MM supplier of biotechnology products. Member of the executive strategic planning team which was responsible for establishing business plans and strategic direction. Managed a business intelligence team responsible for maintaining sales and financial information and advanced analysis tools used across the organization.

• Reorganized the finance and accounting department, including the establishment of short and long-range objectives for the department. Increased the strategic business advisor role of the department and developed a planning and analysis team to what was a traditional accounting organization.

• Assisted in the negotiation of several large business partnership agreements resulting in increased market share and profitability.

• Completed a company valuation study with 3rd-party assistance. This valuation is used for stock option pricing and pricing of stock repurchases.

• Developed a corporate scoreboard and tracking system which was used throughout the organization to manage and measure results against the company’s strategic and operational objectives.

• Successfully implemented a financial reporting and planning system which streamlined the reporting and planning processes and strengthened the accountability to the company’s financial targets and commitments.

• Overhauled the revenue planning methodology, resulting in greater confidence and understanding of the key drivers of the company’s revenue and profit growth plans.

• Initiated the expansion and globalization of the company’s business intelligence systems including roll-out to all twelve international subsidiaries. This series of projects included the development of financial, sales and marketing data warehouses and advanced web-based analysis tools allowing the company’s business leaders access to timely, and comprehensive information.

• Renegotiated the bank line of credit terms and covenants resulting in over $100k of annual savings Fiskars Consumer Products, Madison, WI 1997-2001

DIRECTOR OF FINANCE (1999-2001)

Business group director overseeing all finance related matters for four business units totaling $300 MM in sales. Primary duties included strategic and operational guidance to the business unit teams, financial analysis and reporting to the corporate group, annual budgeting, and strategic planning.

• Selected to work with cross-functional business unit teams to identify and implement organizational consolidations and restructuring resulting in annualized operating savings of $8 MM.

• Designed, implemented and installed a business intelligence system with cross-functional business team assistance. This system provided key managers with customer/product profitability, sales performance and profit contribution, sales forecasting and other financial performance measures. CORPORATE OPERATIONS CONTROLLER (1997-1999)

Responsible for supporting and implementing best practices for the worldwide financial organization, which consisted of 25 companies with $850 MM in sales.

• Played a lead role in the company’s M&A efforts. Performed due diligence, post-acquisition integration, and identified and implemented organizational changes for two U.S. and one international acquisition.

• Oversaw the financial and operational management of the company’s world-wide subsidiaries. Duties required 75%+ travel including international assignments in Finland, Germany, U.K, Sweden, France and Italy.

• Implemented foreign currency hedging procedures under SFAS #133.

• Established international operations accounting and financial reporting policies and procedures. The Pillsbury Company (a subsidiary of Grand Metropolitan Plc.), Minneapolis, MN 1990-1997 SENIOR MANAGER, STRATEGIC COST ANALYSIS (1995-1998) Responsible for Pillsbury’s strategic cost projects and activity-based management efforts. This start-up department was responsible for assisting business teams with identifying, measuring and implementing profit improvements through cost reduction and optimization of supply-chain resources.

• Developed comprehensive customer profitability models using cost-to-serve measurement techniques. These models were used to develop improved sales and marketing strategies resulting in increased profit.

• Moved Pillsbury from a basic cost accounting process by developing and implementing an activity based cost method across the Pillsbury manufacturing sites.

• Selected to lead a project team that analyzed an unprofitable international business unit. The team recommended closing the facility, resulting in $3 MM annual savings. MANAGER, MANUFACTURING SYSTEMS (1993 to 1995)

• Selected to lead a start-up department responsible for establishing functional support for all manufacturing related system (costing, GL, BOM, MRP, maintenance management, time reporting and AP) and to act as a liaison between system users and the headquarters Information Technologies department to improve system R.O.I.

• Successful in eliminating system spending and focusing enhancements on user needs. MANAGER, FINANCIAL REPORTING and CONSOLIDATIONS – Grand Metropolitan Plc. (1990-1993)

• Responsibilities included establishing the financial reporting systems and processes for Grand Metropolitan’s worldwide Food Sector Division following the acquisition of Pillsbury.

• Designed and implemented a corporate-wide reporting and consolidation tool (Hyperion), incorporating both UK and U.S. GAAP reporting requirements. Installed and trained users located in six different European countries and in the U.S. on the application.

•

Banc Services Corporation, Newport, MN 1988-1990

GROUP CONTROLLER

• Responsible for the overall financial controls, budgets and reporting of results for this diversified financial services holding company.

• Managed a $250 MM investment portfolio, increasing returns and diversifying risk

• Financial analysis and recommendation to management on two successful acquisitions and one divestiture. KPMG, Minneapolis, MN 1985-1988

EDUCATION

B.S., Accountancy, University of Wisconsin La Crosse, 1985, Magna Cum Laude, (GPA 3.85/4.00) Executive Leadership Program, Center for Creative Leadership, Colorado Springs, CO, 2000 CERTIFICATIONS

Certified Public Accountant (CPA), 1985

Certified Management Accountant (CMA), 1990

Contact this candidate